The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study.

Johnson, Philip J; Dhanaraj, Sofi; Berhane, Sarah; Bonnett, Laura; Ma, Yuk Ting

Johnson, Philip J; Dhanaraj, Sofi; Berhane, Sarah; Bonnett, Laura; Ma, Yuk Ting.

Affiliation

Johnson PJ; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK. Philip.Johnson@liverpool.ac.uk.
Dhanaraj S; Liver Services, University Hospitals NHS Foundation Trust, Birmingham, UK.
Berhane S; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Bonnett L; Department of Health Data Science, University of Liverpool, Liverpool, UK.
Ma YT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

Br J Cancer ; 125(5): 714-716, 2021 08.

Article in En | MEDLINE | ID: mdl-34127809

Subject(s)

Carcinoma, Hepatocellular/diagnosis; End Stage Liver Disease/diagnosis; Liver Neoplasms/diagnosis; Neutrophils/immunology; Carcinoma, Hepatocellular/immunology; Case-Control Studies; Diagnosis, Differential; End Stage Liver Disease/immunology; Humans; Liver Neoplasms/immunology; Lymphocyte Count; Prognosis; Prospective Studies; Sensitivity and Specificity; Survival Analysis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / End Stage Liver Disease / Liver Neoplasms / Neutrophils Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2021 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google